Hull Hans
Pliant Therapeutics, Inc. · Chief Business Officer
Hull Hans is listed in filings as Chief Business Officer at Pliant Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 27, 2025, including sale activity. Recent filings connect the profile to Pliant Therapeutics, Inc. (PLRX). The current snapshot covers public activity from Jul 11, 2024 to Jan 27, 2025. Reported amounts are shown as $114.4K to $894.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $179k15.9k shares | SellJan 17, 2025 | $11.20 | $1.12 |